Week 1: Hypertension Flashcards
Relate cardiac output, resistance, and blood pressure.
CO = BP/SVR
Relate cardiac output, heart rate, and stroke volume.
CO = HR*SV
Where in the cardiovascular system are baroreceptors located? What are their innervations?
Carotid sinus - glossopharyngeal nerve (IX)
Aortic arch - vagus nerve (X)
Walls of L and R atria at venous entrances - vagus nerve (X)
Describe the physiological effects on the cardiovascular system of increased SNS activity.
Increased release of norepinephrine - acts on alpha-1 receptors to cause vasconstriction
Increased release of epinephrine - acts on beta-1 receptors in the heart to increase chronotropy and inotropy
Describe the physiological effects on the cardiovascular system of decreased PNS activity.
Reduced release of acetylcholine via muscarinic receptors - heart rate increases (slowing effect decreased)
Describe the effect of increased arginine vasopressin on the cardiovascular system. Where is it released from, and in response to what stimulus?
Increases water resorption in kidney distal tubules by activating V2 receptors
Increases vasoconstriction by acting on V1A receptors (only in high concentrations)
Released from posterior pituitary in response to baroreceptors and osmoreceptors
Where is renin released from?
Released from granular cells in the juxtaglomerular apparatus in the kidney
What stimuli result in renin release?
Increased stretch of afferent arteriolar wall (increased ECFV)
Decreased [Na+] and [Cl-] in the distal tubule, detected by the macula densa
SNS (via beta-1 receptors)
Humoral factors (K+, Ang II, ANPs)
What effect does decreased [Na+] and [Cl-] in the distal tubule have?
Decreased resistance in afferent arteriole
Increased renin secretion
What are the effects of angiotensin II?
Vasoconstriction (via AT1 receptor) Synthesis and secretion of aldosterone Release of vasopressin Release of adrenal catecholamines Increased central sympathetic outflow
Describe the action of endothelin. Where is it released from?
Powerful vasoconstrictor - acts on vascular smooth muscle cells via ETA receptor, resulting in calmodulin-mediated activation of MLCK
Synthesized and released from endothelial cells
Describe the action of nitric oxide. Where is it released from?
Vasodilator - diffuses into cell, resulting in inactivation (phosphorylation) of MLCK via a protein kinase G mediated pathway
Synthesized and released from endothelial cells
Describe the action of adenosine in coronary blood vessels.
Vasodilator in coronary blood vessels - binds to A2A receptors, resulting in MLCK inactivation
List causes of primary hypertension.
No direct cause known SNS hyperactivity Abnormal cardiovascular development RAS activity Defect in natriuresis Intracellular sodium and calcium Exacerbating factors
List causes of secondary hypertension.
Renal disease Genetic causes Renal vascular hypertension Primary hyperaldosteronism Cushing's syndrome Pheochromocytoma Coarctation of the aorta Pregnancy associated Estrogen use
List complications of untreated hypertension.
Cerebrovascular disease (stroke) Coronary artery disease Left ventricular hypertrophy Peripheral vascular disease Abdominal and thoracic aortic aneurysm Chronic renal failure (chronic kidney disease)
Summarize the mechanism of action and effects of beta blockers and the receptors that are involved.
Beta blockers inhibit action of endogenous catecholamines:
Decrease cardiac chronotropy, inotropy (beta-1)
Decrease release of renin from kidneys (beta-1)
Decrease SNS activity (beta-1)
List two side effects of beta blockers.
Fatigue (due to reduced CO)
Bronchoconstriction - contraindicated in asthmatics (due to beta-2 antagonism)
Which beta blocker is cardioselective?
Metoprolol (beta-1 only)
Which beta blockers are non-cardioselective?
Propanolol (beta-1 and beta-2)
Carvedilol (alpha-1, beta-1, and beta-2)
Which beta blocker is a partial agonist?
Acebutolol (partial agonist at beta-1)
Describe the effect of dihydropyridines. Give a prototoype.
Vasodilation (main effect)
Reduces cardiac chronotropy, inotropy (minor effect)
Prototype: amlodipine